The efficacy of intensity modulated radiation therapy in treating thyroid-associated ophthalmopathy and predictive factors for treatment response
Authors:
Open Access
- 13 December 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 17533
Abstract
The study evaluated clinical efficacy of intensity modulated radiation therapy (IMRT) in treating patients with thyroid-associated ophthalmopathy (TAO) and defined predictive factors that associated with treatment response. A total of 178 TAO patients were treated with retro-orbital IMRT with radiation dose of 20 Gy in 10 fractions. The immediate and long-term treatment response and complications were evaluated. Besides, logistic-regression analysis was conducted to identify possible predictive factors. TAO symptom score significantly fell from the initiation to 6-month post-treatment (P < 0.001). 134 patients (73.2%) had mild to significant response to IMRT, and 172 patients (96.6%) achieved stabilization of TAO without future progression. Current smoker (OR 2.88, 95% CI 1.32–6.29; P = 0.008) and symptom duration longer than 18 months (OR 3.33, 95% CI 1.24–8.93; P = 0.017) were identified as independent predictive factors for non-response of TAO to retro-orbital IMRT. Immediate complications were slight and self-limited, and long-term complications mainly included chronic xerophthalmias in12 patients (6.74%) and cataract formation in 4 patients (2.25%). The study suggested that IMRT was a viable option for treating TAO patients, with a satisfactory symptom control ability and acceptable post-treatment complications.Keywords
This publication has 32 references indexed in Scilit:
- Comparative analysis of dosimetric parameters of three different radiation techniques for patients with Graves’ ophthalmopathy treated with retro-orbital irradiationRadiation Oncology, 2012
- Clinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgeryRadiation Oncology, 2012
- Outcome of thyroid associated ophthalmopathy treated by radiation therapyRadiation Oncology, 2011
- Effect of Smoking on Orbital Fat and Muscle Volume in Graves' OrbitopathyThyroid®, 2011
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialThe Lancet Oncology, 2011
- Orbital Radiotherapy for Graves' OphthalmopathyThyroid®, 2002
- Graves' ophthalmopathy: current concepts regarding pathogenesis and managementEndocrine Reviews, 1993
- Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathyThe Lancet, 1993
- Pathogenesis of Graves' OphthalmopathyNew England Journal of Medicine, 1992
- Why the NOSPECS Classification of Graves' Eye Disease Should Be Abandoned, with Suggestions for the Characterization of This DiseaseThyroid®, 1992